{"id":453752,"date":"2024-10-20T09:31:56","date_gmt":"2024-10-20T09:31:56","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-iso-232172024\/"},"modified":"2024-10-26T17:41:11","modified_gmt":"2024-10-26T17:41:11","slug":"bs-iso-232172024","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-iso-232172024\/","title":{"rendered":"BS ISO 23217:2024"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 4 Considerations for design inputs 4.1 General 4.2 Risk assessment and usability engineering 4.2.1 Risk assessment 4.2.2 Usability engineering 4.3 Considerations for the determination of requirements for the design of medical devices specific to paediatric users 4.3.1 Considerations in relation to risk (risk-based approach to design) 4.3.2 Considerations in relation to human factors <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 4.3.3 Considerations for accompanying documentation 5 Development of the design <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 6 Design verification and validation 6.1 General 6.2 Design verification 6.3 Design validation 6.3.1 General 6.3.2 Usability evaluations (also known as usability tests or user studies) <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 6.3.3 Clinical evaluation <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | Annex A (informative) Additional considerations for the \u201cpaediatric population\u201d <\/td>\n<\/tr>\n | ||||||
45<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Injection systems for self-administration by paediatric patients. Requirements and guidelines for design<\/b><\/p>\n |